GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Laxmi Organic Industries LXCHEM.NS · INR

Materials · NSE · 🇮🇳 India

Compare

162.57

-0.36%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Laxmi Organic Industries

Its shares trade on NSE under the ticker LXCHEM.NS. It has been listed since 25 March 2021. In the fiscal year to 31 March 2026, it reported revenue of ₹28.47bn and net income of ₹793.6m. At that date it held total assets of ₹34.46bn and shareholders' equity of ₹19.86bn.

Laxmi Organic Industries Ltd. engages in the manufacture of acetyl and specialty intermediates. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2021-03-25. The firm manufactures ethyl acetate, acetic acid and diketene derivative products (DDP). Its business segments include Acetyl Intermediates and Speciality Intermediates. The Acetyl Intermediates segment produces a range of acetyl products, including Bulk Solvents and Aldehydes. The firm manufactures a range of Acetyl products, including bulk solvents and aldehydes. Its acetyl products have applications in diverse industries, such as pharmaceutical formulations, printing inks, adhesives, coatings. The company is also a manufacturer of Speciality Intermediates, such as Ketene & Diketene derivatives, including Esters, Amides and Arylides. Its Speciality Intermediates has applications in pharmaceuticals, synthesis and manufacturing of agrochemicals, pigments, and others. The company also offers custom synthesis of Diketene Derivative Chemicals and Crop and Life Science Intermediates.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Materials
Industry
Chemicals
Listed since
25 Mar 2021
Employees
874
Website
laxmi.com ↗

Leadership

Pay as last reported

  • Mr. Ravi GoenkaExecutive Chairman of the Board, since 1989₹86.9m
  • Dr. Rajan VenkateshChief Executive Officer, Managing Director, Executive Director, since 2023₹66.3m
  • Mr. Mahadeo KarnikChief Financial Officer
  • Mr. Jitendra AgarwalPresident - Essentials BU
  • Mr. Virag ShahPresident - Specialties BU
  • Mr. Prashant PatilExecutive Vice President - Manufacturing (SI)
  • Mr. Aniket HirparaSenior Vice President - Legal and Secretarial, Compliance Officer, Company Secretary, since 2024₹5.9m
  • Mr. Harshvardhan GoenkaExecutive Director, since 2020₹22.9m
  • Dr. Keshav RuthiyaChief Procurement Officer
  • Mr. Manish ChokhaniNon-Executive Director₹2.7m
  • Mr. Rajeev GoenkaNon-Executive Director₹490,000
  • Dr. Rajiv BanavaliNon-Executive Independent Director₹2.6m

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
45
Environment
22
Social
51
Governance
61
Direct emissions (scope 1)
313,807 t
Energy emissions (scope 2)
35,821 t
Women in the workforce
7.86%
Carbon reduction policy
Yes
Human rights policy
Yes

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Laxmi Organic Industries Ltd manufactures ethyl acetate and acetic acid for diverse industrial applications.
  • The company employs 874 full-time staff to produce Acetyl Intermediates and Speciality Intermediates.
  • Speciality Intermediates like Ketene derivatives support pharmaceuticals and agrochemical manufacturing processes effectively.

Weaknesses

  • The company went public on 25 March 2021, indicating a relatively recent market presence.
  • Laxmi Organic Industries Ltd is headquartered in Mumbai, which may limit local operational flexibility.
  • The firm focuses on specific chemical segments, potentially restricting broader market diversification efforts.

Opportunities

  • Diketene Derivative Chemicals offer custom synthesis options for Crop and Life Science Intermediates.
  • Bulk Solvents and Aldehydes have applications in printing inks, adhesives, and coatings sectors.
  • Acetic acid and ethyl acetate production supports growing demands in pharmaceutical formulations.

Threats

  • Reliance on Acetyl Intermediates exposes the company to fluctuations in raw material costs.
  • Speciality Intermediates face competition from other manufacturers of Esters, Amides, and Arylides.
  • Market volatility in the Chemicals sector could impact sales of Diketene derivative products.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.